EC Expected to Clear Syngenta-ChemChina Deal

M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

Event-Driven

<p><span class="s1">The outcome of the planned $43 billion merger between Swiss biotech giant Syngenta and chemical conglomerate ChemChina will mainly depend on whether the parties receive US blessing for the deal, three lawyers familiar with the industry told CTFN.</span></p>

The outcome of the planned $43 billion merger between Swiss biotech giant Syngenta and chemical conglomerate ChemChina will mainly depend on whether the parties receive US blessing for the deal, three lawyers familiar with the industry told CTFN.

Syngenta/ChemChina Merger Hinges on US Approval

Syngenta AG

Syngenta/ChemChina Merger Hinges on US Approval